144 • HSI’s 13 Most Surprising Cures
Their in vitro study^5 found that honokiol sets off the death cycle of these
cancer cells, and that the extract was more toxic toward the B-CLL cells than
healthy cells. On top of that, honokiol also improved the anti-cancer effects of
chemotherapy drugs (fludarabine, cladribine, and chlorambucil).
And that’s not the only difficult cancer that honokiol helps conquer.
According to the National Cancer Institute, “For most patients with
non-small cell lung cancer, current treatments do not cure the cancer.” And
squamous lung cancer fits right into that category. While current mainstream
therapies remain largely ineffective, honokiol (at least in lab tests) appears to
have a very deadly impact on these cancer cells.
When researchers tested honokiol against squamous lung cancer cells in an
in vitro study, their worked paid off. The honokiol treatment set off a chain
reaction that led to apoptosis, cancer cell death.^6
Another study, this one an animal study, found that honokiol on its own
suppressed lung cancer tumors. And when it was combined with first-line
chemotherapy agent DDP (a highly toxic therapy also known as cisplatin),
honokiol boosted its effect: killed off more cancer cells, and prevented the
creation of more tumor-generated blood vessels. On top of that, the adding
honokiol to the DDP “resulted in a significant increase in life span.”^7
Brand new research sees honokiol team up with
a powerful ally to defeat liver cancer
The prognosis for liver cancer (that starts in the liver, rather than spreads
to the liver) is generally very poor, usually just months by the time of diagno-
sis. The treatment options are sparse, and according to the National Institutes
of Health (NIH): “The usual outcome is poor, because only 10 - 20% of hepato-
cellular carcinomas can be removed completely using surgery.”
But once again, honokiol may just save the day, along with a little help from
a specific modified citrus pectin known as PectaSol-C. For this study, researchers
added PectaSol-C, another potent natural cancer killer, to the mix—and the
results (which are not yet published, but have been made available exclusively to
HSI members, thanks to panelist Dr. Isaac Eliaz) are highly promising.
In this in vitro study, liver cancer cells were subjected to honokiol and
PectaSol-C, both separately and together, for 72 hours. The honokiol extract
slowed cancer cell growth by an astonishing rate. (I can’t be more specific until
the study is published later this year, but it really was astonishing.) The Pec-
taSol-C alone reduced cancer cell proliferation by an impressive percentage.
And the synergistic mix of MCP and honokiol substantially decreased the
cancer cells’ life expectancy even more. On top of that, when combined with